Plunkett Research Online: Compugen Ltd

COMPUGEN LTD (CGEN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Compugen Ltd. is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The firm’s therapeutic pipeline consists of immuno-oncol.....



Compugen Ltd
Ticker: CGEN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 972 37658585
Fax: 972 37658555
Address: Azrieli Center, 26 Harokmim Street
Building D
Holon, 5885849 Israel

Types Of Business
Industry Ranks

Industry NAICS code:

Drug Discovery
Biotechnology Databases & Diagnostics
Agricultural Biotechnology
Bioinformatics Platform
ContactsDescription
Anat Cohen DayagCEO/President/Director
Ari KrashinCFO/COO
See More
Compugen Ltd. is a therapeutic discovery and development company utilizing its broadly applicable predictive discovery infrastructure to identify novel drug targets and develop first-in-class therapeutics in the field of cancer immunotherapy. The firm’s therapeutic pipeline consists of immuno-oncol.....See More See More

Auditor: Kost, Forer, Gabbay & Kasierer
Legal Advisor: Meitar Liquornik Geva & Leshem Brandwein
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: